Filing Details
- Accession Number:
- 0001651844-16-000021
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-07-07 18:29:04
- Reporting Period:
- 2016-07-05
- Filing Date:
- 2016-07-07
- Accepted Time:
- 2016-07-07 18:29:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1018735 | Nymox Pharmaceutical Corp | NYMX | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1651844 | George James Robinson | 10 East Lee Street Suite 2705 Baltimore MD 21202 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-07-05 | 2,500 | $3.43 | 2,850,050 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-07-05 | 2,500 | $3.41 | 2,852,550 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-07-06 | 2,500 | $3.33 | 2,855,050 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-07-06 | 2,500 | $3.33 | 2,857,550 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-07-06 | 2,500 | $3.20 | 2,860,050 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-07-06 | 911 | $3.21 | 2,860,961 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-07-07 | 4,089 | $3.17 | 2,865,050 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-07-07 | 2,500 | $3.20 | 2,867,550 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |